Skip to content

Conmed Corp (CNMD) stock: revenue, earnings & dividend

Conmed Corp (CNMD, NYSE): revenue, earnings, dividend and balance sheet from official SEC filings.

Stock screener CNMD · NYSE Medizintechnik & Messgeräte US-FL

Key figures

Fiscal year
2025
Revenue
1.37 bn $
Revenue growth
5.2 %
Revenue growth 5y (p.a.)
9.8 %
Net income
47.1 m $
Net margin
3.4 %
Operating margin
7.5 %
Earnings per share (diluted)
1.51 $
Dividend per share
0.60 $
Payout ratio
39.7 %
Consecutive dividend years
14 years
Consecutive dividend raises
–
Dividend growth 5y (p.a.)
-5.6 %
Total assets
2.33 bn $
Equity
1.03 bn $
Equity ratio
44.4 %
Return on equity
4.6 %
Cash
40.8 m $
Operating cash flow
171 m $
Free cash flow
151 m $
Shares outstanding
29,803,323

History

Revenue by fiscal year

2016 764 m $
2017 796 m $
2018 860 m $
2019 955 m $
2020 862 m $
2021 1.01 bn $
2022 1.05 bn $
2023 1.24 bn $
2024 1.31 bn $
2025 1.37 bn $

Net income by fiscal year

2016 14.7 m $
2017 55.5 m $
2018 40.9 m $
2019 28.6 m $
2020 9.52 m $
2021 62.5 m $
2022 -80.6 m $
2023 64.5 m $
2024 132 m $
2025 47.1 m $

Dividend per share

2016 0.80 $
2017 0.80 $
2018 0.80 $
2019 0.80 $
2020 0.80 $
2021 0.80 $
2022 0.80 $
2023 0.80 $
2024 0.80 $
2025 0.60 $
YearRevenueNet incomeEPSDividend per shareOperating cash flow
20251.37 bn $47.1 m $1.51 $0.60 $171 m $
20241.31 bn $132 m $4.25 $0.80 $167 m $
20231.24 bn $64.5 m $2.04 $0.80 $125 m $
20221.05 bn $-80.6 m $-2.68 $0.80 $33.4 m $
20211.01 bn $62.5 m $1.94 $0.80 $112 m $
2020862 m $9.52 m $0.32 $0.80 $64.5 m $
2019955 m $28.6 m $0.97 $0.80 $95.1 m $
2018860 m $40.9 m $1.41 $0.80 $74.7 m $
2017796 m $55.5 m $1.97 $0.80 $65.6 m $
2016764 m $14.7 m $0.52 $0.80 $39.9 m $

Data from XBRL filings at the SEC, processed automatically, no guarantee. Not investment advice. All filings at the SEC (EDGAR)